0001493152-22-022147.txt : 20220811
0001493152-22-022147.hdr.sgml : 20220811
20220811172950
ACCESSION NUMBER: 0001493152-22-022147
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20220811
DATE AS OF CHANGE: 20220811
EFFECTIVENESS DATE: 20220811
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Biofrontera Inc.
CENTRAL INDEX KEY: 0001858685
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 473765675
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-455731
FILM NUMBER: 221157048
BUSINESS ADDRESS:
STREET 1: 120 PRESIDENTIAL WAY,
STREET 2: SUITE 330
CITY: WOBURN
STATE: MA
ZIP: 01801
BUSINESS PHONE: 781-245-1325
MAIL ADDRESS:
STREET 1: 120 PRESIDENTIAL WAY,
STREET 2: SUITE 330
CITY: WOBURN
STATE: MA
ZIP: 01801
D
1
primary_doc.xml
X0708
D
LIVE
0001858685
Biofrontera Inc.
120 PRESIDENTIAL WAY,
SUITE 330
WOBURN
MA
MASSACHUSETTS
01801
781-245-1325
DELAWARE
None
None
Corporation
true
John
J III
Borer
120 Presidential Way, Suite 330
Woburn
MA
MASSACHUSETTS
01801
Director
Beth
J
Hoffman
120 Presidential Way, Suite 330
Woburn
MA
MASSACHUSETTS
01801
Director
Hermann
Luebbert
120 Presidential Way, Suite 330
Woburn
MA
MASSACHUSETTS
01801
Executive Officer
Director
Kevin
D
Weber
120 Presidential Way, Suite 330
Woburn
MA
MASSACHUSETTS
01801
Director
Loretta
M
Wedge
120 Presidential Way, Suite 330
Woburn
MA
MASSACHUSETTS
01801
Director
Erica
L
Monaco
120 Presidential Way, Suite 330
Woburn
MA
MASSACHUSETTS
01801
Executive Officer
Erica
F
Gates
120 Presidential Way, Suite 330
Woburn
MA
MASSACHUSETTS
01801
Executive Officer
Pharmaceuticals
Decline to Disclose
- 06b
false
2022-07-27
false
true
true
true
false
0
7114287
7114287
0
Total offering amount and total amount sold includes warrants to purchase 4,285,715 shares of common stock. See the Company's Form 8-K filed with the SEC on July 28, 2022 regarding the transaction.
false
1
0
0
0
false
Biofrontera Inc.
/s/ Erica Monaco
Erica Monaco
Chief Executive Officer
2022-08-11